Bamco Inc Myriad Genetics Inc Transaction History

Bamco Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$20.93 - $35.1 $5.97 Million - $10 Million	-285,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $5.74 Million - $12.2 Million	-260,000 Reduced 47.71%	285,000 $8.16 Million
Q2 2019 Aug 15, 2019	BUY	$22.67 - $35.0 $803,334 - $1.24 Million	35,436 Added 6.95%	545,000 $15.1 Million
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $3.82 Million - $4.93 Million	142,000 Added 38.63%	509,564 $16.9 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $2.93 Million - $4.9 Million	107,564 Added 41.37%	367,564 $10.7 Million
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $555,000 - $803,400	20,000 Added 8.33%	260,000 $9.72 Million
Q1 2018 May 09, 2018	BUY	$28.83 - $41.01 $1.59 Million - $2.26 Million	55,000 Added 29.73%	240,000 $7.09 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $867,725 - $1.13 Million	-30,500 Reduced 14.15%	185,000 $6.35 Million
Q3 2017 Nov 15, 2017	BUY	$24.01 - $36.2 $5.17 Million - $7.8 Million	215,500	215,500 $7.8 Million

233

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.13B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.